Table 1 Cohort characteristics
n | % | |
|---|---|---|
Total cohort (n = 233) | ||
Age | ||
Mean/median age | 23-85 y | |
Range | 49/47 y | |
Tumor stage (FIGO | ||
Ia | 4 | (1.7) |
Ib | 139 | (59.7) |
IIa | 17 | (7.3) |
IIb | 48 | (20.6) |
IIIb | 1 | (0.4) |
IVa | 7 | (3.0) |
IVb | 17 | (7.4) |
Postoperative residual tumor | ||
R0 | 212 | (91.0) |
R1 | 21 | (9.0) |
Subcohort with follow-up informations (n = 178) | ||
Applied therapy regimen | ||
Observation | 86 | (48.3) |
Adjuvant radiotherapy alone | 42 | (23.6) |
Adjuvant chemoradiotherapy | 50 | (28.0) |
Clinical follow-up | ||
Median follow-up time: 49 months | ||
Recurrence | 47 | (25.4) |
Dead of disease (DOD) | 41 | (22.2) |